Lester Crawford – Alliance for Human Research Protection

October 26, 2006

The Crawford Resignation Mystery

The Crawford Resignation Mystery Sat, 24 Sep 2005 Merrill Goozner of Center for Science in the Public

The Crawford Resignation Mystery

October 26, 2006

At FDA, Changes In Name Only–Agency Puts Business interests Above Safety

At FDA, Changes In Name Only–Agency Puts Business interests Above Safety Fri, 30 Sep 2005 The sudden

At FDA, Changes In Name Only–Agency Puts Business interests Above Safety

October 26, 2006

How Did the Vioxx Debacle Happen? USA Today / Lancet

How Did the Vioxx Debacle Happen? USA Today / Lancet Tue, 12 Oct 2004 Dr. Eric Topol

How Did the Vioxx Debacle Happen? USA Today / Lancet

October 26, 2006

FDA Commissioner Nominee told Senate He’s Open to Independent Safety Unit / Avonex Warning

FDA Commissioner Nominee told Senate He’s Open to Independent Safety Unit / Biogen issues Avonex Warning Fri,

FDA Commissioner Nominee told Senate He’s Open to Independent Safety Unit / Avonex Warning

October 26, 2006

Infomail Archive

Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the

Infomail Archive

October 26, 2006

Pfizer CEO earned $16 milion – 72% Increase / V-P Tells Congress How to Save $37.8 billion in cost of drugs

Pfizer CEO earned $16 milion-72% Increase / V-P Tells Congress How to Save $37.8 billion in cost

Pfizer CEO earned $16 milion – 72% Increase / V-P Tells Congress How to Save $37.8 billion in cost of drugs

October 26, 2006

Corporate Culture of Denial Results in Preventable Deaths

Corporate Culture of Denial Results in Preventable Deaths Fri, 7 Jan 2005 Failure to disclose the hazardous

Corporate Culture of Denial Results in Preventable Deaths

October 26, 2006

FDA Commissioner Lester Crawford Resigns – AP

FDA Commissioner Lester Crawford Resigns – AP Fri, 23 Sep 2005 The Associated Press reports that the

FDA Commissioner Lester Crawford Resigns – AP

October 26, 2006

Safety of American Drugs Questioned – Assoc Press

Safety of American Drugs Questioned – Assoc Press Thu, 2 Dec 2004 In his CNN news program

Safety of American Drugs Questioned – Assoc Press

October 26, 2006

FDA Critics Slam Plan for Safety Reform – Nature

FDA Critics Slam Plan for Safety Reform – Nature Thu, 17 Feb 2005 This is smoke and

FDA Critics Slam Plan for Safety Reform – Nature

October 26, 2006

FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post

FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post Thu, 18 Nov 2004

FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post

October 26, 2006

Cover Letter – Comments to FDA Re Anthrax Vaccine

Cover Letter – AHRP Ethical and Scientific Objections to FDA’s Proposed Licensure of Anthrax Vaccine related links:

Cover Letter – Comments to FDA Re Anthrax Vaccine

October 26, 2006

Daniel Troy Legacy: Public Virtually Defenseless against Unsafe Drugs

Daniel Troy Legacy: Public Virtually Defenseless against Unsafe Drugs Thu, 18 Nov 2004 The Associated Press reports

Daniel Troy Legacy: Public Virtually Defenseless against Unsafe Drugs

October 26, 2006

Infomail Archive, 2005

Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the

Infomail Archive, 2005

Load More Articles

ALLIANCE FOR HUMAN RESEARCH PROTECTION

The Crawford Resignation Mystery

At FDA, Changes In Name Only–Agency Puts Business interests Above Safety

How Did the Vioxx Debacle Happen? USA Today / Lancet

FDA Commissioner Nominee told Senate He’s Open to Independent Safety Unit / Avonex Warning

Pfizer CEO earned $16 milion – 72% Increase / V-P Tells Congress How to Save $37.8 billion in cost of drugs

Corporate Culture of Denial Results in Preventable Deaths

FDA Commissioner Lester Crawford Resigns – AP

Safety of American Drugs Questioned – Assoc Press

FDA Critics Slam Plan for Safety Reform – Nature

FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post

Daniel Troy Legacy: Public Virtually Defenseless against Unsafe Drugs

Subscribe to Our Newsletter!